Sign in

    Christopher Madison • William Blair

    Christopher Madison is a Managing Director and Senior Research Analyst at William Blair, specializing in Healthcare Services and Outsourcing. He covers prominent companies such as UnitedHealth Group, Cigna, Humana, and HCA Healthcare, and is recognized for his analytical rigor and actionable investment recommendations. Since joining William Blair in 2006, Madison has built a solid reputation for accurate stock calls and strong buy/sell ratings, consistently ranking among top analysts for healthcare sector performance with success rates over 60% on platforms like TipRanks. He holds multiple FINRA securities licenses, including Series 7, 63, 86, and 87, and is respected for his in-depth industry knowledge and insightful client interactions.

    Christopher Madison's questions to Ooma Inc (OOMA) leadership

    Christopher Madison's questions to Ooma Inc (OOMA) leadership • Q2 2025

    Question

    Christopher Madison, on for Arjun Bhatia, asked about the drivers behind the increase in net retention to 100% and its expected trend. He also requested an update on the progress and customer feedback for AirDial in Canada since its recent launch.

    Answer

    CFO Shigeyuki Hamamatsu attributed the net retention improvement to lower churn among business users but cautioned it could dip back to 99% in the second half due to the anticipated IWG churn. CEO Eric Stang described the AirDial launch in Canada as off to a 'good start' with a reseller partner and some wins, but acknowledged that more market development is needed to tap the full opportunity.

    Ask Fintool Equity Research AI